贝达药业：MRX-2843项目仍在进行转化医学探索研究

Group 1 - The core point of the article is that Beida Pharmaceutical is conducting exploratory research on a new drug, MRX-2843, which targets a novel mechanism and is currently in translational medicine studies to identify precise patient populations for its indications [2] Group 2 - The company has indicated that any significant progress regarding MRX-2843 will be disclosed to the public in a timely manner [2]